Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. (Q53523902)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. |
scientific article |
Statements
Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. (English)
Quantin X
Rivière A
Daurès JP
Oliver P
Comte-Bardonnet M
Khial F
Marcillac I
Pujol JL
1 April 2000
23
2
192-196